Name | Title | Contact Details |
---|
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.
A World Leader in Pediatric Healthcare Founded in 1950 by Variety Clubs International, Nicklaus Children s Hospital, formerly Miami Children s Hospital, operates South Florida’s only licensed specialty hospital exclusively for children, with more than 650 attending physicians and over 130 pediatric sub-specialists. The 289-bed nonprofit hospital is renowned for excellence in all aspects of pediatric medicine and routinely has many programs ranked among the nation’s best by U.S. News & World Report. The organization has grown and evolved into the Miami Children s Health System (MCHS) which includes Miami Children s Health Foundation, the organization s 501c3 fundraising arm; a network of eight nonprofit outpatient centers situated in Miami-Dade, Broward and Palm Beach counties; Pediatric Specialty Group, Inc., a nonprofit physician practice subsidiary; a management services organization, and an ambulatory surgery center (opening soon), as well as an e-commerce line of children s wellness and safety products that support the hospital s mission of serving the region’s pediatric population. MCHS is the region’s only healthcare system exclusively for children.
Gilda'S Club is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1987, Health Level Seven (HL7) is an ANSI-accredited non-profit that empowers global health data interoperability by developing standards and enabling their adoption and implementation – for a world where everyone can securely access and use the right health data when and where they need it.